89 related articles for article (PubMed ID: 1476856)
21. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides.
Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D
Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450-dependent transformations of 15R- and 15S-hydroperoxyeicosatetraenoic acids: stereoselective formation of epoxy alcohol products.
Chang MS; Boeglin WE; Guengerich FP; Brash AR
Biochemistry; 1996 Jan; 35(2):464-71. PubMed ID: 8555216
[TBL] [Abstract][Full Text] [Related]
23. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
Marathe PH; Shen DD; Nelson WL
Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
[TBL] [Abstract][Full Text] [Related]
24. Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat.
Law MY; Slawson MH; Moody DE
Drug Metab Dispos; 2000 Mar; 28(3):348-53. PubMed ID: 10681381
[TBL] [Abstract][Full Text] [Related]
25. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital.
He K; Falick AM; Chen B; Nilsson F; Correia MA
Chem Res Toxicol; 1996; 9(3):614-22. PubMed ID: 8728507
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic mechanisms in the metabolic activation of N-nitrosodialkylamines.
Yang CS; Patten C; Lee MJ; Li M; Yoo JS; Pan J; Hong J
IARC Sci Publ; 1987; (84):104-8. PubMed ID: 3679343
[TBL] [Abstract][Full Text] [Related]
27. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
Ng SF; Waxman DJ
Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
[TBL] [Abstract][Full Text] [Related]
28. Enantioselective 2-hydroxylation of RS-8359, a selective and reversible MAO-A inhibitor, by cytochrome P450 in mouse and rat liver microsomes.
Itoh K; Nishiya Y; Takasaki W; Adachi M; Tanaka Y
Chirality; 2006 Aug; 18(8):592-8. PubMed ID: 16642492
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of the polynuclear sulfur heterocycle benzo[b]phenanthro[2,3-d]thiophene by rodent liver microsomes: evidence for multiple pathways in the bioactivation of benzo[b]phenanthro[2,3-d]thiophene.
Yuan ZX; Sikka HC; Munir S; Kumar A; Muruganandam AV; Kumar S
Chem Res Toxicol; 2003 Dec; 16(12):1581-8. PubMed ID: 14680372
[TBL] [Abstract][Full Text] [Related]
30. The stereoselective metabolism of halofantrine to desbutylhalofantrine in the rat: evidence of tissue-specific enantioselectivity in microsomal metabolism.
Gharavi N; Sattari S; Shayeganpour A; El-Kadi AO; Brocks DR
Chirality; 2007 Jan; 19(1):22-33. PubMed ID: 17089336
[TBL] [Abstract][Full Text] [Related]
31. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
Prough RA; Brown MI; Dannan GA; Guengerich FP
Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
Carlile DJ; Hakooz N; Houston JB
Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
[TBL] [Abstract][Full Text] [Related]
33. Fate of isopropyl-iodoamphetamine (IMP) in rat liver microsomes.
Joulin Y; Moretti JL; Hoellinger H; Defer G
Nucl Med Commun; 1992 Feb; 13(2):99-105. PubMed ID: 1436904
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines. XIII. Enzyme interactions with a series of beta-alkyl-substituted 2-phenylethanamines and corresponding N-hydroxylamines.
Jönsson KH; Stefek M; Lindeke B
Acta Pharm Nord; 1992; 4(2):105-9. PubMed ID: 1388750
[TBL] [Abstract][Full Text] [Related]
35. Cyclopropylamine inactivation of cytochromes P450: role of metabolic intermediate complexes.
Cerny MA; Hanzlik RP
Arch Biochem Biophys; 2005 Apr; 436(2):265-75. PubMed ID: 15797239
[TBL] [Abstract][Full Text] [Related]
36. The stereoselective metabolism of ethylamphetamine with fortified rabbit liver homogenates.
Beckett AH; Haya K
Xenobiotica; 1978 Feb; 8(2):85-96. PubMed ID: 626007
[TBL] [Abstract][Full Text] [Related]
37. On the formation of cytochrome P-450 product complexes during the metabolism of phenylalkylamines.
Jonsson J; Lindeke B
Acta Pharm Suec; 1976; 13(4):313-20. PubMed ID: 998274
[No Abstract] [Full Text] [Related]
38. [Kinetics of N-dealkylation of amines with participation of microsomal cytochrome P-450].
Akhrem AA; Bel'skiĭ SM; Metelitsa DI
Biokhimiia; 1978 Jan; 43(1):23-7. PubMed ID: 23870
[TBL] [Abstract][Full Text] [Related]
39. Differentiation between type I and type II substrate binding to cytochrome P-450 by variation of temperature.
Misselwitz R; Jänig GR; Rein H; Buder E; Zirwer D; Ruckpaul K
Acta Biol Med Ger; 1976; 35(5):K 19-25. PubMed ID: 983603
[TBL] [Abstract][Full Text] [Related]
40. [Effect of temperature on the interaction of cytochrome P-450 with a variety of amines].
Akhrem AA; Bel'skiĭ SM; Metelitsa DI
Biokhimiia; 1977 Dec; 42(12):2116-20. PubMed ID: 597514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
